297,298 Additionally, two other key trials of SGLT-is in people with CKD showed that canagliflozin reduced the primary composite outcome of ESRD (dialysis, transplantation, or a sustained estimated eGFR 45 ml/min/1.73m 2 and a urinary-to-creatinine ratio (uACR) 25 mg/mmol or 2045 ml/min/1.73 m 2 or established CVD are recommended for diabetic patients because of its high glucose-lowering efficacy and proven cardiorenal benefits
Take control of your health without unnecessary barriers or insurance complications
If you have noticed changes in your bowel habits or seen blood in your stool while taking GLP-1 medications, it is natural to feel a sense of alarm
Proper titration and provider monitoring help avoid these complications
Every body is different thats why we customize your entire plan around what works best for you
While they share a common origin in growth hormone signaling, their mechanisms, specificity, and research applications differ significantly